AngioDynamics ANGO Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Gross Profit by Business | |||||
| Med Device | $79.19M-9.5% | $87.5M-22.1% | $112.28M-0.8% | $113.15M-3.5% | |
| Med Tech | $78.52M+16.8% | $67.2M+8.4% | $61.97M+17.8% | $52.58M+33.0% | |
| Net Sales by Product | |||||
| Med Device | $165.84M-16.0% | $197.51M-18.4% | $242.07M+1.9% | $237.5M+0.9% | |
| Med Tech | $126.65M+19.0% | $106.4M+10.0% | $96.69M+22.8% | $78.72M+41.2% | |
| Net Sales by Geography | |||||
| International | $41.52M-20.8% | $52.43M-6.4% | $56.04M+11.5% | $50.26M-6.9% | |
| United States | $250.98M-0.2% | $251.49M-11.0% | $282.71M+6.3% | $265.96M+12.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AngioDynamics break its business down?
- AngioDynamics (ANGO) reports gross profit by business across 2 parts — Med Device and Med Tech. Each is extracted from the segment footnotes and tracked over time.
- Where does AngioDynamics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AngioDynamics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
